Prostate cancer, version 1.2016

Featured updates to the NCCN guidelines

James L. Mohler, Andrew J. Armstrong, Robert R. Bahnson, Anthony Victor D'Amico, Brian J. Davis, James A. Eastham, Charles Arthur Enke, Thomas A. Farrington, Celestia S. Higano, Eric M. Horwitz, Michael Hurwitz, Christopher J. Kane, Mark H. Kawachi, Michael Kuettel, Richard J. Lee, Joshua J. Meeks, David F. Penson, Elizabeth R. Plimack, Julio M. Pow-Sang, David Raben & 12 others Sylvia Richey, Mack Roach, Stan Rosenfeld, Edward Schaeffer, Ted A. Skolarus, Eric J. Small, Guru Sonpavde, Sandy Srinivas, Seth A. Strope, Jonathan Tward, Dorothy A. Shead, Deborah A. Freedman-Cass

Research output: Contribution to journalArticle

327 Citations (Scopus)

Abstract

The NCCN Guidelines for Prostate Cancer address staging and risk assessment after an initial diagnosis of prostate cancer and management options for localized, regional, and metastatic disease. Recommendations for disease monitoring, treatment of recurrent disease, and systemic therapy for metastatic castration-recurrent prostate cancer also are included. This article summarizes the NCCN Prostate Cancer Panel's most significant discussions for the 2016 update of the guidelines, which include refinement of risk stratification methods and new options for the treatment of men with high-risk and very-high-risk disease and progressive castration-naïve disease.

Original languageEnglish (US)
Pages (from-to)19-30
Number of pages12
JournalJNCCN Journal of the National Comprehensive Cancer Network
Volume14
Issue number1
StatePublished - Jan 1 2016

Fingerprint

Prostatic Neoplasms
Guidelines
Castration
Neoplasm Staging
Therapeutics

ASJC Scopus subject areas

  • Oncology

Cite this

Mohler, J. L., Armstrong, A. J., Bahnson, R. R., D'Amico, A. V., Davis, B. J., Eastham, J. A., ... Freedman-Cass, D. A. (2016). Prostate cancer, version 1.2016: Featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network, 14(1), 19-30.

Prostate cancer, version 1.2016 : Featured updates to the NCCN guidelines. / Mohler, James L.; Armstrong, Andrew J.; Bahnson, Robert R.; D'Amico, Anthony Victor; Davis, Brian J.; Eastham, James A.; Enke, Charles Arthur; Farrington, Thomas A.; Higano, Celestia S.; Horwitz, Eric M.; Hurwitz, Michael; Kane, Christopher J.; Kawachi, Mark H.; Kuettel, Michael; Lee, Richard J.; Meeks, Joshua J.; Penson, David F.; Plimack, Elizabeth R.; Pow-Sang, Julio M.; Raben, David; Richey, Sylvia; Roach, Mack; Rosenfeld, Stan; Schaeffer, Edward; Skolarus, Ted A.; Small, Eric J.; Sonpavde, Guru; Srinivas, Sandy; Strope, Seth A.; Tward, Jonathan; Shead, Dorothy A.; Freedman-Cass, Deborah A.

In: JNCCN Journal of the National Comprehensive Cancer Network, Vol. 14, No. 1, 01.01.2016, p. 19-30.

Research output: Contribution to journalArticle

Mohler, JL, Armstrong, AJ, Bahnson, RR, D'Amico, AV, Davis, BJ, Eastham, JA, Enke, CA, Farrington, TA, Higano, CS, Horwitz, EM, Hurwitz, M, Kane, CJ, Kawachi, MH, Kuettel, M, Lee, RJ, Meeks, JJ, Penson, DF, Plimack, ER, Pow-Sang, JM, Raben, D, Richey, S, Roach, M, Rosenfeld, S, Schaeffer, E, Skolarus, TA, Small, EJ, Sonpavde, G, Srinivas, S, Strope, SA, Tward, J, Shead, DA & Freedman-Cass, DA 2016, 'Prostate cancer, version 1.2016: Featured updates to the NCCN guidelines', JNCCN Journal of the National Comprehensive Cancer Network, vol. 14, no. 1, pp. 19-30.
Mohler JL, Armstrong AJ, Bahnson RR, D'Amico AV, Davis BJ, Eastham JA et al. Prostate cancer, version 1.2016: Featured updates to the NCCN guidelines. JNCCN Journal of the National Comprehensive Cancer Network. 2016 Jan 1;14(1):19-30.
Mohler, James L. ; Armstrong, Andrew J. ; Bahnson, Robert R. ; D'Amico, Anthony Victor ; Davis, Brian J. ; Eastham, James A. ; Enke, Charles Arthur ; Farrington, Thomas A. ; Higano, Celestia S. ; Horwitz, Eric M. ; Hurwitz, Michael ; Kane, Christopher J. ; Kawachi, Mark H. ; Kuettel, Michael ; Lee, Richard J. ; Meeks, Joshua J. ; Penson, David F. ; Plimack, Elizabeth R. ; Pow-Sang, Julio M. ; Raben, David ; Richey, Sylvia ; Roach, Mack ; Rosenfeld, Stan ; Schaeffer, Edward ; Skolarus, Ted A. ; Small, Eric J. ; Sonpavde, Guru ; Srinivas, Sandy ; Strope, Seth A. ; Tward, Jonathan ; Shead, Dorothy A. ; Freedman-Cass, Deborah A. / Prostate cancer, version 1.2016 : Featured updates to the NCCN guidelines. In: JNCCN Journal of the National Comprehensive Cancer Network. 2016 ; Vol. 14, No. 1. pp. 19-30.
@article{cdb39471119044a492181d97779a1e50,
title = "Prostate cancer, version 1.2016: Featured updates to the NCCN guidelines",
abstract = "The NCCN Guidelines for Prostate Cancer address staging and risk assessment after an initial diagnosis of prostate cancer and management options for localized, regional, and metastatic disease. Recommendations for disease monitoring, treatment of recurrent disease, and systemic therapy for metastatic castration-recurrent prostate cancer also are included. This article summarizes the NCCN Prostate Cancer Panel's most significant discussions for the 2016 update of the guidelines, which include refinement of risk stratification methods and new options for the treatment of men with high-risk and very-high-risk disease and progressive castration-na{\"i}ve disease.",
author = "Mohler, {James L.} and Armstrong, {Andrew J.} and Bahnson, {Robert R.} and D'Amico, {Anthony Victor} and Davis, {Brian J.} and Eastham, {James A.} and Enke, {Charles Arthur} and Farrington, {Thomas A.} and Higano, {Celestia S.} and Horwitz, {Eric M.} and Michael Hurwitz and Kane, {Christopher J.} and Kawachi, {Mark H.} and Michael Kuettel and Lee, {Richard J.} and Meeks, {Joshua J.} and Penson, {David F.} and Plimack, {Elizabeth R.} and Pow-Sang, {Julio M.} and David Raben and Sylvia Richey and Mack Roach and Stan Rosenfeld and Edward Schaeffer and Skolarus, {Ted A.} and Small, {Eric J.} and Guru Sonpavde and Sandy Srinivas and Strope, {Seth A.} and Jonathan Tward and Shead, {Dorothy A.} and Freedman-Cass, {Deborah A.}",
year = "2016",
month = "1",
day = "1",
language = "English (US)",
volume = "14",
pages = "19--30",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "1",

}

TY - JOUR

T1 - Prostate cancer, version 1.2016

T2 - Featured updates to the NCCN guidelines

AU - Mohler, James L.

AU - Armstrong, Andrew J.

AU - Bahnson, Robert R.

AU - D'Amico, Anthony Victor

AU - Davis, Brian J.

AU - Eastham, James A.

AU - Enke, Charles Arthur

AU - Farrington, Thomas A.

AU - Higano, Celestia S.

AU - Horwitz, Eric M.

AU - Hurwitz, Michael

AU - Kane, Christopher J.

AU - Kawachi, Mark H.

AU - Kuettel, Michael

AU - Lee, Richard J.

AU - Meeks, Joshua J.

AU - Penson, David F.

AU - Plimack, Elizabeth R.

AU - Pow-Sang, Julio M.

AU - Raben, David

AU - Richey, Sylvia

AU - Roach, Mack

AU - Rosenfeld, Stan

AU - Schaeffer, Edward

AU - Skolarus, Ted A.

AU - Small, Eric J.

AU - Sonpavde, Guru

AU - Srinivas, Sandy

AU - Strope, Seth A.

AU - Tward, Jonathan

AU - Shead, Dorothy A.

AU - Freedman-Cass, Deborah A.

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The NCCN Guidelines for Prostate Cancer address staging and risk assessment after an initial diagnosis of prostate cancer and management options for localized, regional, and metastatic disease. Recommendations for disease monitoring, treatment of recurrent disease, and systemic therapy for metastatic castration-recurrent prostate cancer also are included. This article summarizes the NCCN Prostate Cancer Panel's most significant discussions for the 2016 update of the guidelines, which include refinement of risk stratification methods and new options for the treatment of men with high-risk and very-high-risk disease and progressive castration-naïve disease.

AB - The NCCN Guidelines for Prostate Cancer address staging and risk assessment after an initial diagnosis of prostate cancer and management options for localized, regional, and metastatic disease. Recommendations for disease monitoring, treatment of recurrent disease, and systemic therapy for metastatic castration-recurrent prostate cancer also are included. This article summarizes the NCCN Prostate Cancer Panel's most significant discussions for the 2016 update of the guidelines, which include refinement of risk stratification methods and new options for the treatment of men with high-risk and very-high-risk disease and progressive castration-naïve disease.

UR - http://www.scopus.com/inward/record.url?scp=84969516736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84969516736&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 19

EP - 30

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

SN - 1540-1405

IS - 1

ER -